Tango Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

Go back to Tango Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
(NASDAQ: TNGX) Delayed: 22.66 +0.14 (0.62%)
Previous Close $22.52    52 Week High
Open $22.50    52 Week Low
Day High $23.08    P/E N/A 
Day Low $22.26    EPS
Volume 251,791